Search Results - "Chehrazi-Raffle, Alexander"

Integration of PSMA-Targeted Theranostics into Multidisciplinary Care for Improved Efficiencies and Patient Care.

Authors: Kuo, Phillip H. Poku, Erasmus Kofi Yamauchi, Dave M. et al.

Source: Journal of Nuclear Medicine Technology. Dec2025, Vol. 53 Issue 4, p300-304. 5p.

Disparities in Outcomes in Latino Subpopulations with Localized Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Analysis.

Authors: Jaime-Casas, Salvador Barragan-Carrillo, Regina Kothari, Anjaney et al.

Source: Cancers. Mar2026, Vol. 18 Issue 6, p1035. 14p.

Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion.

Authors: Mercier, Benjamin D. Govindarajan, Ameish Castro, Daniela V. et al.

Source: Cancer Medicine. Apr2025, Vol. 14 Issue 7, p1-8. 8p.

The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies.

Authors: Gong, Jun Chehrazi‐Raffle, Alexander Placencio‐Hickok, Veronica et al.

Source: Clinical & Translational Medicine. Dec2019, Vol. 8 Issue 1, p1-14. 14p.

Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California.

Authors: Salgia, Nicholas J. Chehrazi-Raffle, Alexander Hsu, JoAnn et al.

Source: Cancer Medicine. Aug2021, Vol. 10 Issue 16, p5671-5680. 10p.

Clinical Predictors and Prognostic Significance of Pathologic Disease Upstaging at Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer.

Authors: Jaime-Casas, Salvador Yip, Wesley Lama, Daniel J. et al.

Source: Cancers. Oct2025, Vol. 17 Issue 19, p3265. 13p.

An Update on the Treatment of Papillary Renal Cell Carcinoma.

Authors: Chawla, Neal S. Sayegh, Nicolas Prajapati, Sweta et al.

Source: Cancers. Feb2023, Vol. 15 Issue 3, p565. 12p.

Erratum: Genomic Risk Classifiers in Localized Prostate Cancer: Precise but Not Standardized.

Authors: Góes, Vitor Li, Yu Jun Chehrazi-Raffle, Alexander

Source: JCO Precision Oncology. 10/15/2025, Vol. 9, p1-1. 1p.

Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma.

Authors: Chehrazi-Raffle, Alexander Dorff, Tanya B. Pal, Sumanta K. et al.

Source: Cancers. 2/15/2021, Vol. 13 Issue 4, p889-889. 1p.